A new study suggests that a vaccine targeting Epstein-Barr virus may prevent infectious mononucleosis, commonly known as “mono” or “glandular fever.” EBV is a member of the herpes virus family and one of the most common viruses in humans, with nearly all adults in developed countries such as the United States having been infected.